Structure-based design of biocatalytic panels for pharmaceuticals synthesis

16 November 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Biocatalysis is emerging as an attractive option for manufacturing pharmaceuticals. However, the identification of enzymes for target transformations of interest requires major screening efforts. Here we report a structure-based computational workflow to prioritize protein sequences by a score based on predicted activities on substrates, thereby reducing resource intensive laboratory-based biocatalyst screening. We selected imine reductases (IREDs) as a class of biocatalysts to illustrate the application of the computational workflow termed IREDFisher. Validation by using published data showed that IREDFisher can retrieve the best enzymes and increase the hit rate by identifying the top 20 ranked sequences. The power of IREDFisher is confirmed by computationally screening 1,400 sequences to identify suitable biocatalysts for five selected reductive amination reactions. IREDFisher is available as a user-friendly web interface that will enable rapid identification of biocatalysts for applications in synthesis and directed evolution studies with minimal time and resource expenditure.


enzyme discovery
imine reductase
homology modelling

Supplementary weblinks


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.